Related Experiment Video
Updated: Jun 6, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
Aseptic lymphocyte-dominated vasculitis-associated lesion: a clinicopathologic review of an underrecognized cause of
Tyler Steven Watters1, Diana M Cardona, K Sunil Menon
1Division of Orthopaedic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
It is estimated that 35% of total hip arthroplasties (THAs) involve a second-generation metal-on-metal (MOM) prosthesis. A novel complication has appeared in a subset of patients with MOM THAs that is described as an aseptic, lymphocyte-dominated vasculitis-associated lesion (ALVAL). The clinical features of ALVAL are nonspecific, but patients complain of pain and may develop "pseudotumors." It is hypothesized that metal ions are released from the prosthesis and form haptens with native proteins that elicit a type IV hypersensitivity response in the local soft tissues. Histopathologic descriptions of ALVAL are similar to those of failed arthroplasty in general, with the addition of a dense perivascular inflammatory infiltrate that is the hallmark of ALVAL. We report 3 cases of ALVAL with clinical, radiographic, and histologic findings. Accurate assessment is crucial because an intraoperative diagnosis of chronic inflammation suggestive of ALVAL will necessitate a replacement of the prosthetic component surfaces.
Insights
Metal-on-metal hip replacements can cause a rare complication called aseptic, lymphocyte-dominated vasculitis-associated lesion (ALVAL). Early diagnosis of ALVAL is vital for effective treatment and to prevent further complications.
Area of Science:
- Orthopedic Surgery
- Immunology
- Biomaterials Science
Background:
- Metal-on-metal (MOM) total hip arthroplasties (THAs) are used in an estimated 35% of cases.
- A subset of patients with MOM THAs develop a novel complication known as aseptic, lymphocyte-dominated vasculitis-associated lesion (ALVAL).
Observation:
- ALVAL presents with nonspecific clinical features, including pain and potential pseudotumor formation.
- Histopathology reveals findings similar to general arthroplasty failure, but with a characteristic dense perivascular inflammatory infiltrate.
Findings:
- Metal ions released from MOM prostheses may form haptens with proteins.
- This is hypothesized to trigger a type IV hypersensitivity response in local soft tissues.
- Three cases of ALVAL are presented with detailed clinical, radiographic, and histologic findings.
Implications:
- Accurate and timely diagnosis of ALVAL is crucial for patient outcomes.
- Intraoperative identification of chronic inflammation suggestive of ALVAL necessitates replacement of prosthetic component surfaces.
- Understanding the immunologic response to MOM THAs can inform future implant design and patient selection.
Related Concept Videos
Cytotoxic Edema: Pathophysiology
Endocarditis II: Clinical Features of Infective Endocarditis
Peripheral Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction